News for hackers. Stuff that matters.
Re:Covid: Remdesivir 'has little or no effect' on survival, ... by gregwebs on Friday October 16, 2020 @02:30PM (#24803611)
Strong evidence for a benefit is often measured by death or something extremely severe.

When using other clinical endpoints cherry-picking is to be avoided. [1]

> For a trial to stop early for benefit, the observed effect on the composite end point ideally should be consistent in the individual components.

[1] https://www.ahajournals.org/doi/full/10.1161/circheartfailur...

There are no comments on this comment yet.